PTPRJ
Receptor-type tyrosine-protein phosphatase eta
Also known as: CD148, DEP1, HPTPeta, PTPRJ_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q12913
- Gene
- PTPRJ
- Ensembl
- ENSG00000149177
- Chromosome
- 11
- Canonical length
- 1337 aa
- Protein class
- CD markers, Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins
- Subcellular location
- Nucleoplasm,Nucleoli,Nuclear bodies,Cell Junctions
- Secretome location
- Secreted to blood
OverviewNCBI Gene
The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes, including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP possesses an extracellular region containing five fibronectin type III repeats, a single transmembrane region, and a single intracytoplasmic catalytic domain, and thus represents a receptor-type PTP. This protein is present in all hematopoietic lineages, and was shown to negatively regulate T cell receptor signaling possibly through interfering with the phosphorylation of Phospholipase C Gamma 1 and Linker for Activation of T Cells. This protein can also dephosphorylate the PDGF beta receptor, and may be involved in UV-induced signal transduction. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
1337 residues, UniProt reviewed canonical sequence.
>Q12913|PTPRJ
1 MKPAAREARL PPRSPGLRWA LPLLLLLLRL GQILCAGGTP SPIPDPSVAT VATGENGITQ
61 ISSTAESFHK QNGTGTPQVE TNTSEDGESS GANDSLRTPE QGSNGTDGAS QKTPSSTGPS
121 PVFDIKAVSI SPTNVILTWK SNDTAASEYK YVVKHKMENE KTITVVHQPW CNITGLRPAT
181 SYVFSITPGI GNETWGDPRV IKVITEPIPV SDLRVALTGV RKAALSWSNG NGTASCRVLL
241 ESIGSHEELT QDSRLQVNIS GLKPGVQYNI NPYLLQSNKT KGDPLGTEGG LDASNTERSR
301 AGSPTAPVHD ESLVGPVDPS SGQQSRDTEV LLVGLEPGTR YNATVYSQAA NGTEGQPQAI
361 EFRTNAIQVF DVTAVNISAT SLTLIWKVSD NESSSNYTYK IHVAGETDSS NLNVSEPRAV
421 IPGLRSSTFY NITVCPVLGD IEGTPGFLQV HTPPVPVSDF RVTVVSTTEI GLAWSSHDAE
481 SFQMHITQEG AGNSRVEITT NQSIIIGGLF PGTKYCFEIV PKGPNGTEGA SRTVCNRTVP
541 SAVFDIHVVY VTTTEMWLDW KSPDGASEYV YHLVIESKHG SNHTSTYDKA ITLQGLIPGT
601 LYNITISPEV DHVWGDPNST AQYTRPSNVS NIDVSTNTTA ATLSWQNFDD ASPTYSYCLL
661 IEKAGNSSNA TQVVTDIGIT DATVTELIPG SSYTVEIFAQ VGDGIKSLEP GRKSFCTDPA
721 SMASFDCEVV PKEPALVLKW TCPPGANAGF ELEVSSGAWN NATHLESCSS ENGTEYRTEV
781 TYLNFSTSYN ISITTVSCGK MAAPTRNTCT TGITDPPPPD GSPNITSVSH NSVKVKFSGF
841 EASHGPIKAY AVILTTGEAG HPSADVLKYT YEDFKKGASD TYVTYLIRTE EKGRSQSLSE
901 VLKYEIDVGN ESTTLGYYNG KLEPLGSYRA CVAGFTNITF HPQNKGLIDG AESYVSFSRY
961 SDAVSLPQDP GVICGAVFGC IFGALVIVTV GGFIFWRKKR KDAKNNEVSF SQIKPKKSKL
1021 IRVENFEAYF KKQQADSNCG FAEEYEDLKL VGISQPKYAA ELAENRGKNR YNNVLPYDIS
1081 RVKLSVQTHS TDDYINANYM PGYHSKKDFI ATQGPLPNTL KDFWRMVWEK NVYAIIMLTK
1141 CVEQGRTKCE EYWPSKQAQD YGDITVAMTS EIVLPEWTIR DFTVKNIQTS ESHPLRQFHF
1201 TSWPDHGVPD TTDLLINFRY LVRDYMKQSP PESPILVHCS AGVGRTGTFI AIDRLIYQIE
1261 NENTVDVYGI VYDLRMHRPL MVQTEDQYVF LNQCVLDIVR SQKDSKVDLI YQNTTAMTIY
1321 ENLAPVTTFG KTNGYIALocalizationUniProt · AlphaFold · HPA
Whether an antibody against PTPRJ can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 26 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 26 nTPM
- spleen: 22 nTPM
- appendix: 19 nTPM
- thyroid gland: 18 nTPM
- parathyroid gland: 15 nTPM
- lymph node: 14 nTPM
Single-cell type
- neutrophils: 3,323 nCPM
- neutrophil progenitors: 1,713 nCPM
- renal collecting duct intercalated cells: 1,340 nCPM
- tuft cells: 1,095 nCPM
- microglia: 976 nCPM
- proximal tubule cells: 833 nCPM
Immune cell
- neutrophil: 9.5 nTPM
- non-classical monocyte: 4.8 nTPM
- eosinophil: 2.7 nTPM
- intermediate monocyte: 2 nTPM
- gdT-cell: 1.6 nTPM
- plasmacytoid DC: 1.5 nTPM
Brain region
- thalamus: 51 nTPM
- choroid plexus: 50 nTPM
- cerebral cortex: 43 nTPM
- white matter: 42 nTPM
- basal ganglia: 40 nTPM
- hypothalamus: 40 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PTPRJ.
Disease | AllUniProt
Conditions PTPRJ is implicated in, by any mechanism.
- Thrombocytopenia 10 (THC10) MIM:620484
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 262 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Thrombocytopenia 10
- Carcinoma of colon
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.63
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.97
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- angiogenesis
- axon guidance
- B cell differentiation
- blood coagulation
- contact inhibition
- cytokine-mediated signaling pathway
- glucose homeostasis
- heart development
- negative regulation of cell growth
- negative regulation of cell migration
- negative regulation of cell population proliferation
- negative regulation of epidermal growth factor receptor signaling pathway
- negative regulation of insulin receptor signaling pathway
- negative regulation of MAP kinase activity
- negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- negative regulation of platelet-derived growth factor receptor signaling pathway
- negative regulation of T cell receptor signaling pathway
- negative regulation of vascular permeability
- oligodendrocyte differentiation
- peptidyl-tyrosine dephosphorylation
- platelet formation
- platelet-derived growth factor receptor signaling pathway
- positive chemotaxis
- positive regulation of calcium-mediated signaling
- positive regulation of cell adhesion
- positive regulation of Fc receptor mediated stimulatory signaling pathway
- positive regulation of focal adhesion assembly
- positive regulation of macrophage chemotaxis
- positive regulation of MAPK cascade
- positive regulation of phagocytosis
- positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- positive regulation of platelet activation
- positive regulation of tumor necrosis factor production
- regulation of cell adhesion
- signal transduction
- T cell receptor signaling pathway
- vasculogenesis
Molecular functions
- beta-catenin binding
- cadherin binding
- delta-catenin binding
- gamma-catenin binding
- mitogen-activated protein kinase binding
- phosphatase activity
- platelet-derived growth factor receptor binding
- protein kinase binding
- protein tyrosine phosphatase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Tyrosine-specific protein phosphatase, PTPase domain
- Tyrosine-specific protein phosphatases domain
- Protein-tyrosine phosphatase, catalytic
- Fibronectin type III
- Immunoglobulin-like fold
- Protein-tyrosine phosphatase, active site
- Protein-tyrosine phosphatase-like
- Fibronectin type III superfamily
- PTPRJ, transmembrane domain
- Receptor-type Tyrosine-protein Phosphatases/Ushers
- Fibronectin type III domain
- Protein-tyrosine phosphatase
- TM proximal of protein tyrosine phosphatase, receptor type J
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PTPRJ in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PTPRJ as an antibody target. Whether an autoantibody or antibody against PTPRJ could matter depends on whether native PTPRJ is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PTPRJ is annotated at the cell surface, where native PTPRJ is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PTPRJ as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...